From: Androgen receptor status predicts response to chemotherapy, not risk of breast cancer in Indian women
Group
Cases (N = 70)
Controls (N = 80)
P value
AR1AR1
30 (42.8%)
45 (56.2%)
Referent
AR1AR2
15 (21.4%)
7 (8.7%)
0.02
AR2AR2
25 (35.7%)
28 (35.0%)
0.47